Spruce Biosciences, Inc.
SPRB
$176.91
$17.9011.26%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
10/14/2025
-
MarketBeat
10/11/2025
-
MarketBeat
10/10/2025
-
Ticker Report
10/8/2025
-
GuruFocus
10/8/2025
-
GuruFocus
10/8/2025
-
GuruFocus
10/8/2025
-
GuruFocus
10/8/2025
-
GuruFocus
10/8/2025
-
The Fly
10/8/2025
-
Seeking Alpha - Healthcare
10/8/2025
-
The Fly
10/8/2025
-
Business Wire
10/7/2025
-
IB Times - Technology
10/7/2025
-
Stocktwits News Feed
10/7/2025
-
The Fly
10/7/2025
-
The Fly
10/7/2025
-
Stocktwits News Feed
10/7/2025
-
TipRanks Financial Blog
10/7/2025
-
Benzinga
10/6/2025
-
MarketBeat
10/6/2025
-
MarketBeat
10/6/2025
-
GuruFocus
10/6/2025
-
Investor's Business Daily
10/6/2025
-
MarketBeat
10/6/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, August 14, 2025
Period Date
Monday, June 30, 2025
Next Filing
Week of Nov 10 and 14 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
415 655 4168
Address
611 Gateway Boulevard
South San Francisco, CA 94080
South San Francisco, CA 94080
Country
Year Founded
Business Description
Sector
Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company develops TA-ERT, a fusion protein...
more